Rapport Therapeutics (RAPP) Insider Trading & Ownership $16.01 +1.38 (+9.43%) Closing price 08/26/2025 04:00 PM EasternExtended Trading$15.75 -0.26 (-1.63%) As of 05:42 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Rapport Therapeutics (NASDAQ:RAPP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.57%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$161.25KNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$365.50K Get RAPP Insider Trade Alerts Want to know when executives and insiders are buying or selling Rapport Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RAPP Insider Buying and Selling by Quarter Rapport Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/15/2025David BredtInsiderSell8,500$15.00$127,500.00 7/15/2025David BredtInsiderSell8,500$14.00$119,000.00 7/15/2025David BredtInsiderSell8,500$14.00$119,000.00 3/12/2025Troy A IgnelziCFOBuy9,900$10.10$99,990.00 3/12/2025Wendy B YoungDirectorBuy6,000$10.21$61,260.00 (Data available from 1/1/2013 forward) RAPP Insider Trading Activity - Frequently Asked Questions Who is on Rapport Therapeutics' Insider Roster? The list of insiders at Rapport Therapeutics includes David Bredt, James Healy, Troy A Ignelzi, and Wendy B Young. Learn more on insiders at RAPP. What percentage of Rapport Therapeutics stock is owned by insiders? 13.57% of Rapport Therapeutics stock is owned by insiders. Learn more on RAPP's insider holdings. Which Rapport Therapeutics insiders have been buying company stock? The following insiders have purchased RAPP shares in the last 24 months: James Healy ($1,079,664.64), Troy A Ignelzi ($99,990.00), and Wendy B Young ($61,260.00). How much insider buying is happening at Rapport Therapeutics? Insiders have purchased a total of 59,932 RAPP shares in the last 24 months for a total of $1,240,914.64 bought. Which Rapport Therapeutics insiders have been selling company stock? The following insider sold RAPP shares in the last 24 months: David Bredt ($365,500.00). How much insider selling is happening at Rapport Therapeutics? Insiders have sold a total of 25,500 Rapport Therapeutics shares in the last 24 months for a total of $365,500.00 sold. More Insider Trading Tools from MarketBeat Related Companies IDYA Insider Trading SRPT Insider Trading HRMY Insider Trading IRON Insider Trading ARQT Insider Trading ADPT Insider Trading CGON Insider Trading ANIP Insider Trading VCEL Insider Trading BEAM Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Reynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big Upside This page (NASDAQ:RAPP) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapport Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapport Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access